Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Alice Norton reflects on what the new Pandemic Agreement means for global health security.

Portrait of Alice Norton

After weeks of headlines about cuts to global health, scientists being locked out of their labs and life-saving clinical trials and vaccine research being put on hold due to US and other global funding cuts, confidence in collaborative global health security was waning. 

Today’s adoption of the Pandemic Agreement at the World Health Assembly in Geneva offers resounding hope that common sense and shared goodwill towards humanity will, eventually, prevail.

It might have taken over three years of challenging discussions and amendments, but today’s commitment by 124 countries is a historic decision. 

This is the first such health-related agreement to be successfully negotiated by the World Health Organization (WHO) and the duration of negotiations reflects complexities in gaining agreement across member states. 

Keeping pandemic preparedness on the agenda

Pandemic preparedness is still one of the most pressing challenges in global health. The fact that we have faced a pandemic recently does not make it any less likely that we are about to face another. 

While we’ve come a long way since the start of the Covid pandemic in some areas like vaccines and data sharing, in others – like the political will to work together and invest in biosecurity the same way we invest in defence – progress has stalled. 

Ultimately the success of this Pandemic Agreement will depend on national investment, and across all countries this will require renewed political will beyond the Health Ministries. 

 

Read the full story on the Pandemic Sciences Institute website.

 

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience